Rescue of pressure overload-induced heart failure by estrogen therapy

Journal of the American Heart Association

Volumn 5, Issue 1, 2016, Pages 1-12

  Iorga, Andrea ^a   Li, Jingyuan ^a   Sharma, Salil ^a   Umar, Soban ^a   Bopassa, Jean C ^a,c   Nadadur, Rangarajan D ^a   Centala, Alexander ^a   Ren, Shuxun ^a   Saito, Tomoaki ^a,b,d   Toro, Ligia ^a   Wang, Yibin ^a,b   Stefani, Enrico ^a,b   Eghbali, Mansoureh ^a  

^a Institute of Molecular Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Ministry of International Trade and Industry   (Japan)

Author keywords

Angiogenesis; Aromatase; Estrogen; Fibrosis; Heart failure

Indexed keywords

AROMATASE; ATRIAL NATRIURETIC FACTOR; ESTROGEN; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYOSIN HEAVY CHAIN BETA; PROTEIN KINASE B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; VASCULOTROPIN; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVATION; ESTROGEN SYNTHESIS; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OVERLOAD; HEART PROTECTION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; UPREGULATION; ANGIOGENESIS; ANIMAL; BLOOD; C57BL MOUSE; CARDIAC MUSCLE CELL; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FIBROSIS; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; AROMATASE; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; FIBROSIS; HEART FAILURE; MALE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84998816213     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002482     Document Type: Article

References (36)

1. Chien KRaAAG. In: Barunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia, PA: Saunders Company; 1996:1626_1648.
2. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA. Chronic inhibition of cyclic GMP phospho- diesterase 5A prevents and reverses cardiac hypertrophy. Nat Med.2005;11:214_222.
3. Sasaki H, Nagayama T, Blanton RM, Seo K, Zhang M, Zhu G, Lee DI, Bedja D, Hsu S, Tsukamoto O, Takashima S, Kitakaze M, Mendelsohn ME, Karas RH, Kass DA, Takimoto E. PDE5 inhibitor efficacy is estrogen dependent in female heart disease. J Clin Invest. 2014;124:2464_2471.
4. Kamal FA, Mickelsen DM, Wegman KM, Travers JG, Moalem J, Hammes SR, Smrcka AV, Blaxall BC. Simultaneous adrenal and cardiac g-protein-coupled receptor-Gbc inhibition halts heart failure progression. J Am Coll Cardiol.2014;63:2549_2557.
5. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17beta-Estradiol attenuates the development of pressure-overload hypertrophy.Circulation. 2001;104:1419_1423.
6. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA. 1991;88:8277_8281.
7. Zhou YQ, Foster FS, Parkes R, Adamson SL. Developmental changes in left and right ventricular diastolic filling patterns in mice. Am J Physiol Heart Circ Physiol. 2003;285:H1563_H1575.
8. Dorn GW, Robbins J, Sugden PH. Phenotyping hypertrophy: eschew obfuscation.Circ Res. 2003;92:1171_1175.
9. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol. 1999;34:264_273.
10. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-Induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444_448.
11. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108_2118.
12. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000;35:36_44.
13. Bhuiyan MS, Shioda N, Fukunaga K. Ovariectomy augments pressure overloadinduced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats. Am J Physiol Endocrinol Metab. 2007;293: E1606_E1614.
14. Tagashira H, Bhuiyan S, Shioda N, Fukunaga K. Distinct cardioprotective effects of 17beta-estradiol and dehydroepiandrosterone on pressure overloadinduced hypertrophy in ovariectomized female rats. Menopause.2011;18:1317_1326.
15. Grohe C, Kahlert S, Lobbert K, Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis 6. J Endocrinol.1998;156:R1_R7.
16. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids. 2002;67:979_983.
17. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA. 2000;97:12735_12740.
18. Takeda K. Sarcolemmal slow conductance increase of frog sartorius fibers during hyperpolarization. Jpn J Physiol. 1975;25:515_524.
19. Ling S, Dai A, Dilley RJ, Jones M, Simpson E, Komesaroff PA, Sudhir K. Endogenous estrogen deficiency reduces proliferation and enhances apoptosis- related death in vascular smooth muscle cells: insights from the aromatase-knockout mouse. Circulation. 2004;109:537_543.
20. Flamme I, Breier G, Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol. 1995;169:699_712.
21. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, Hurn PD. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke. 2005;36: 337_341.
22. Rodger FE, Young FM, Fraser HM, Illingworth PJ. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod.1997;12:1723_1729.
23. Elkin M, Orgel A, Kleinman HK. An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst. 2004;96:875_878.
24. Kyriakides ZS, Petinakis P, Kaklamanis L, Sbarouni E, Karayannakos P, Iliopoulos D, Dontas I, Kremastinos DT. Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. Cardiovasc Res. 2001;49:626_633.
25. Ng YS, D'Amore PA. Therapeutic angiogenesis for cardiovascular disease. Curr Control Trials Cardiovasc Med. 2001;2:278_285.
26. Taimeh Z, Loughran J, Birks EJ, Bolli R. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol. 2013;10:519_530.
27. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz-Zagrosek V. 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res. 2010;85:719_728.
28. Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L, Meng QJ, Travis M, Prehar S, Berry A, Hanley NA, Neyses L, Xiao RP, Oceandy D, Ke Y, Solaro RJ, Cartwright EJ, Lei M, Wang X. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circ Heart Fail. 2013;6:833_ 844.
29. Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T, Mendelsohn ME, Karas RH. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail. 2008;14:245_253.
30. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER. Estrogen receptorbeta prevents cardiac fibrosis. Mol Endocrinol. 2010;24:2152_2165.
31. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res. 2003;36:1143_1158.
32. Han G, Ma H, Chintala R, Miyake K, Fulton DJ, Barman SA, White RE. Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling. Am J Physiol Heart Circ Physiol. 2007;293:H314_H321.
33. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol.1995;26:807_814.
34. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res. 2010;106:1681_1691.
35. Gardner JD, Murray DB, Voloshenyuk TG, Brower GL, Bradley JM, Janicki JS. Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am J Physiol Heart Circ Physiol. 2010;298: H497_H504.
36. Umar S, Iorga A, Matori H, Nadadur RD, Li J, Maltese F, van DER LA, Eghbali M. Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med. 2011;184:715_723.